Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallamini

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana LinfomiS Luminari, I Biasoli, L Arcaini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)S Luminari, I Biasoli, A Versari, et al.
Leukemia|February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive diseaseF R Mauro, S Chauvie, F Paoloni, et al.
British Journal of Cancer|January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-BG Todeschini, S Secchi, E Morra, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational StudyJ M Zaucha, B Malkowski, S Chauvie, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana LinfomiS Luminari, I Biasoli, L Arcaini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)S Luminari, I Biasoli, A Versari, et al.
Leukemia|February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive diseaseF R Mauro, S Chauvie, F Paoloni, et al.
British Journal of Cancer|January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-BG Todeschini, S Secchi, E Morra, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational StudyJ M Zaucha, B Malkowski, S Chauvie, et al.
Pageof 7